指南与共识银屑病与炎症性皮肤病皮肤肿瘤湿疹皮炎与荨麻疹

炎症性皮肤病治疗结局的性别差异系统综述:是否该制定新指南?

A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?
指南 / 共识 · J Eur Acad Dermatol Venereol · 2024-07-30

性别差异主要体现在治疗选择、治疗启动时间、治疗反应、不良事件、依从性和治疗满意度,银屑病在所有方面均发现性别差异,但其他皮肤病仍缺乏专门研究。

要点

  • 银屑病治疗结局在治疗选择、启动时间、反应、不良事件、依从性和满意度均存在性别差异。
  • 其他炎症性、感染性和自身免疫性皮肤病缺乏性别差异的专门研究。
  • 皮肤病性别特异性诊疗存在明显证据缺口,需优化以患者为中心的个体化医疗。

核心结论

  • 该系统综述显示皮肤病治疗结局存在诸多性别差异,同时揭示皮肤科性别特异性诊疗存在重大缺口,应于未来几年缩小以优化以患者为中心、个体化、性别平等的医疗。

研究设计与样本

  • 纳入英文和德文的随机对照试验、前瞻性和回顾性队列及病例对照研究,评估男女在皮肤病治疗结局上的差异。
  • 由两位作者独立筛选报告,一位提取全部数据(第二位复核),并批判性评估研究质量和偏倚风险。

主要发现

  • 纳入报告中最大份额聚焦银屑病和银屑病关节炎的性别差异(n=49),其次为黑色素瘤(n=8),其他炎症性、感染性和自身免疫性皮肤病仅有零星研究(n<5)。
  • 可识别性别差异的主要主题为治疗选择、治疗启动时间、治疗反应、不良事件、依从性和治疗满意度。
  • 对于银屑病,所有上述方面均发现性别差异;对于其他皮肤病,仍缺乏关于性别差异的专门发表。

临床怎么用

  • 临床应关注银屑病治疗中治疗选择、启动时间、反应、不良事件、依从性和满意度的性别差异。
  • 对其他炎症性、感染性和自身免疫性皮肤病,需警惕性别差异证据不足,决策时应个体化评估。

局限性

  • 其他皮肤病关于性别差异的专门发表仍缺失,证据主要集中在银屑病和银屑病关节炎。
  • 仅纳入英文和德文研究,可能限制语言覆盖范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gender- and sex-specific differences in medicine were long-time disregarded. Despite numerous indications of gender- and sex-specific influences on the treatment of dermatological conditions, these have not yet been systematically investigated. OBJECTIVES: To meet this unmet need, we conducted the present systematic review on the topic of gender and sex differences in the treatement outcome of skin diseases. METHODS: Embase (via Ovid), PubMed Medline and Web of Science were searched, in between January 2001 and December 2022. English and german randomized controlled trials, prospective and retrospective cohorts and case-control studies that examined differences between men and women in treatment outcomes of skin diseases were included. RESULTS: Two authors independently screened the reports for eligibility, one extracted all data (the second double-checked) and critically appraised the quality and risk of bias of the studies. Eighty-three reports were included. The largest share of the identified publications focused on gender differences in psoriasis and psoriatic arthritis (n = 49), followed by melanoma (n = 8) and sporadic studies (n < 5) of inflammatory, infectious and autoimmune skin diseases. The main topics in which gender differences could be identified were choice of treatment, time to initiation of treatment, therapy response, adverse events, adherence and treatment satisfaction. For psoriasis, gender differences could be found in all aspects, while for the other skin diseases specific publications on gender differences are still missing. CONCLUSIONS: This systematic review shows numerous gender differences but also reveals major gaps in gender-specific care in dermatology which should be narrowed in the upcoming years to optimize a patient-centred, individualized, gender-equal healthcare. PROSPERO Registration: CRD42022306626.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Preis S, Ziehfreund S, Biedermann T, et al. A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines? J Eur Acad Dermatol Venereol. 2024. PMID: 39078087. doi:10.1111/jdv.20256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。